European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Eureka Therapeutics Inc., Emeryville, United States

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Eureka Therapeutics Inc.

Identification

Lei
549300XW368SBE7KX822

Address

5858 Horton Street, Suite 170, Emeryville 94608, United States

Financials

History

Publications

27 Aug 2025
Patent: Antibodies To Mucin-16 And Methods To Use It
13 Nov 2024
Patent: Chimeric Antigen Receptors Targeting FC Receptor-Like 5 and Uses Thereof
10 Apr 2024
Patent: Antibody/T-Cell Receptor Chimeric Constructs and Uses Thereof
5 Feb 2024
Patent: Compositions Including Anti-WT-1 Antibodies & Antigen Binding Fragments and Uses Thereof
6 Dec 2023
Patent: Novel PD-1 Immune Modulating Agents
11 Oct 2023
Patent: Anti-B Cell Maturation Antigen Chimera Antigen Receptors and Uses
2 May 2023
Patent: Compositions Targeting GPC2 and GPC3 and Their USE for Treating Solid Tumors
29 Sept 2022
Wordmark: “ARTEMIS“
1 Oct 2021
Wordmark: “INVISIMASK“
29 Jul 2021
Patent: T Cells and Chimeric Stimulating Receptors and Uses Thereof
24 Jul 2020
Patent: Chimeric Antigen Receptor T Cells and Uses Thereof
24 Jul 2020
Patent: Cells Expressing Chimeric Antigen Receptors and Chimeric Stimulating Receptors and Uses Thereof
7 May 2020
Patent: Humanized Antibodies to Mucin-16 and Methods of USE Thereof
14 Nov 2019
Patent: Antibodies to Mucin-16 and Methods of USE Thereof
29 Mar 2019
Patent: Constructs Targeting CD22 and Uses Thereof
24 Apr 2018
Patent: Specifically Glypican 3 Recognizing Constructs and Their Uses
24 Apr 2018
Patent: Cells for Expression of Chimeric Activation Receptors and Chimeric Stimulation Receptors and Uses Thereof
22 Feb 2018
Wordmark: “EUREKA THERAPEUTICS“
11 Oct 2017
Patent: T Cell Receptor-Like Antibodies Specific for a WT1 Peptide Presented by HLA-A2
22 Sept 2017
Patent: Constructs Targeting HIV Peptide/MHC Complexes and Uses Thereof
13 Jan 2017
Patent: T Cell Receptor-Like Antibodies Specific for Foxp3-Derived Peptides
9 Jun 2016
Patent: T Cell Receptor-Like Antibody Agents Specific for EBV Latent Membrane Protein 2A Peptide Presented by Human HLA
1 Apr 2016
Patent: Constructs Targeting AFP Peptide/MHC Complexes and Uses Thereof
4 Dec 2015
Patent: Chimeric Antigen Receptors Targeting FC Receptor-Like 5 and Uses Thereof
7 Nov 2014
Patent: FC-Enhanced Anti-WT1/HLA Antibody
21 Jul 2009
Patent: Cell Lines and Proteins with Variant Glycosylation Pattern
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.